Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3.01 – $13.50
84% from low
No one on the platform currently holds EKSO.
No tracked institution reports a position in EKSO as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-06-02 | 1-for-15reverse |
| 2020-03-25 | 1-for-15reverse |
| 2016-05-05 | 1-for-7reverse |
No one on the platform has traded EKSO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $19M | +31.8% | $-0.10 | $-0.10–$-0.10 | — | 1 |
| 2027 | $24M | +25.9% | $-0.06 | $-0.06–$-0.06 | — | 1 |
| 2028 | $31M | +25.4% | $0.03 | $0.03–$0.03 | 393.3× | 1 |
| 2029 | $38M | +24.6% | $0.14 | $0.14–$0.14 | 84.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-04-28 | $-0.03 | $-2.04 | -6700.0% |
| 2026-02-23 | $-0.08 | $-1.56 | -1850.0% |
| 2025-10-28 | $-0.99 | $-0.54 | +45.5% |
| 2025-07-28 | $-1.20 | $-1.24 | -3.3% |
| 2025-05-05 | $-1.65 | $-1.80 | -9.1% |
| 2025-03-03 | $-0.07 | $-0.14 | -100.0% |
| 2024-10-28 | $-0.08 | $-0.10 | -25.0% |
| 2024-07-29 | $-0.11 |
| $-0.13 |
| -18.2% |
| $25M |
| — |
| CODXCo-Diagnostics, Inc. | $1.49 | +0.68% | $2M | — |
| ERNAErnexa Therapeutics Inc. | $4.30 | -2.71% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry